Acumen Pharmaceuticals, Inc.ABOSNASDAQ
Loading
Year-over-year gross profit growth rate
Latest
0.00%
↓ 100% vs avg
Percentile
P32
Within normal range
Average
12.15%
Historical baseline
| Period | Value |
|---|---|
| Q3 2025 | 0.00% |
| Q2 2025 | 0.00% |
| Q1 2025 | 100.00% |
| Q4 2024 | 0.00% |
| Q3 2024 | 0.00% |
| Q2 2024 | 0.00% |
| Q1 2024 | 100.00% |
| Q4 2023 | 91.75% |
| Q3 2023 | 94.82% |
| Q2 2023 | -4.82% |
| Q1 2023 | 18.92% |
| Q4 2022 | -29.33% |
| Q3 2022 | -13.50% |
| Q2 2022 | -22.32% |
| Q1 2022 | -5.50% |
| Q4 2021 | -215.17% |
| Q3 2021 | 20.14% |
| Q2 2021 | 0.00% |
| Q1 2021 | 100.00% |
| Q4 2020 | 69.21% |
| Q3 2020 | -27.48% |
| Q2 2020 | 2.63% |
| Q1 2020 | 0.00% |